BNB PLUS CORP.

Profile

Company Names

BNB PLUS CORP.
APPLIED DNA SCIENCES INC

Addresses

25 HEALTH SCIENCES DRIVE, STONY BROOK, NY 11790

50 HEALTH SCIENCES DRIVE, STONY BROOK, NY 11790

25 HEALTH SCIENCES DRIVE, SUITE 215, STONY BROOK, NY 11790

25 HEALTH SCIENCES DRIVE, SUITE 113, STONY BROOK, NY 11790

Phone Numbers

631-240-8800
631 240-8800
631 444 6861

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$91,885,416.00

Number of Funding Rounds:

20
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
20
2026-05-28 
$2,500,000.00 
$5,000,000.00 
$2,500,000.00 
Equity 
19
2025-09-29 
$58,000,000.00 
$58,000,000.00 
$0.00 
Equity 
18
2024-10-30 
$0.00 
$13,325,000.00 
$13,325,000.00 
Equity 
17
2024-02-02 
$0.00 
$6,874,466.00 
$6,874,466.00 
Equity 
16
2020-10-07 
$1,198,860.00 
$3,690,830.00 
$2,491,970.00 
Equity 
15
2019-08-22 
$418,000.00 
$418,000.00 
$0.00 
Equity 
14
2019-07-16 
$1,500,000.00 
$1,500,000.00 
$0.00 
Debt 
13
2018-08-31 
$1,650,000.00 
$3,500,000.00 
$1,850,000.00 
Debt 
12
2017-06-28 
$805,000.00 
$1,805,000.00 
$1,000,000.00 
Equity 
11
2016-11-07 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
10
2015-11-23 
$25,000.00 
$5,400,000.00 
$5,375,000.00 
 
9
2014-09-11 
$1,800,000.00 
$1,800,000.00 
$0.00 
Debt 
8
2014-06-03 
$2,145,956.00 
$2,145,956.00 
$0.00 
Equity 
7
2013-07-19 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
6
2012-11-28 
$2,000,000.00 
$7,500,000.00 
$5,500,000.00 
Equity 
5
2012-06-21 
$1,542,600.00 
$1,542,600.00 
$0.00 
Equity 
4
2011-07-15 
$5,000,000.00 
$10,000,000.00 
$5,000,000.00 
Equity 
3
2010-11-17 
$350,000.00 
$3,000,000.00 
$2,650,000.00 
Equity, Debt 
2
2010-07-15 
$0.00 
$2,000,000.00 
$2,000,000.00 
Equity, Debt 
1
2009-02-27 
$450,000.00 
$2,000,000.00 
$1,550,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT 
 
ANCHIN 
DIRECTOR
APPLIED DNA SCIENCES INC
JOHN 
 
BITZER, III 
DIRECTOR
2D2C INC   |  APPLIED DNA SCIENCES INC
ROBERT 
B. 
CATELL 
DIRECTOR
BIORESTORATIVE THERAPIES, INC.   |  APPLIED DNA SCIENCES INC   |  BNB PLUS CORP.
GERALD 
 
CATENACCI 
DIRECTOR
APPLIED DNA SCIENCES INC   |  FIELD SAFE SOLUTIONS INC.
JOSEPH 
D 
CECCOLI 
DIRECTOR
APPLIED DNA SCIENCES INC
JOSEPH 
D. 
CECCOLI 
DIRECTOR
APPLIED DNA SCIENCES INC   |  BNB PLUS CORP.
KAROL 
 
GRAY 
DIRECTOR, EXECUTIVE OFFICER
APPLIED DNA SCIENCES INC
JAMES 
 
HAFT 
DIRECTOR
DLT DATA CENTER 1 LLC   |  BNB PLUS CORP.
JAMES 
A 
HAYWARD 
EXECUTIVE OFFICER, DIRECTOR
APPLIED DNA SCIENCES INC
JAMES 
A. 
HAYWARD 
EXECUTIVE OFFICER, DIRECTOR
APPLIED DNA SCIENCES INC
BETH 
 
JANTZEN 
EXECUTIVE OFFICER
APPLIED DNA SCIENCES INC
BETH 
M. 
JANTZEN 
EXECUTIVE OFFICER
BNB PLUS CORP.
KURT 
 
JENSEN 
EXECUTIVE OFFICER
KEY PLASTICS CORP   |  APPLIED DNA SCIENCES INC
KURT 
H. 
JENSEN 
EXECUTIVE OFFICER
APPLIED DNA SCIENCES INC
JOSHUA 
 
KRUGER 
DIRECTOR
LUMINOSITY PARTNERS LP   |  BNB PLUS CORP.
MING-HWA 
 
LIANG 
EXECUTIVE OFFICER
APPLIED DNA SCIENCES INC
MING-HWA 
BENJAMIN 
LIANG 
EXECUTIVE OFFICER
APPLIED DNA SCIENCES INC
JUDITH 
 
MURRAH 
EXECUTIVE OFFICER, DIRECTOR
APPLIED DNA SCIENCES INC   |  BNB PLUS CORP.
JUDY 
 
MURRAH 
EXECUTIVE OFFICER
APPLIED DNA SCIENCES INC
CHARLES 
 
RYAN 
DIRECTOR
APPLIED DNA SCIENCES INC   |  FASTEN INC   |  TOLOKA GROUP, INC.   |  QUINCE THERAPEUTICS, INC.
CHARLES 
S. 
RYAN 
DIRECTOR
ABS MATERIALS, INC.   |  BIORESTORATIVE THERAPIES, INC.   |  APPLIED DNA SCIENCES INC
ELIZABETH 
M. 
SCHMALZ FERGUSON 
DIRECTOR
APPLIED DNA SCIENCES INC
ELIZABETH 
M. 
SCHMALZ SHAHEEN 
DIRECTOR
APPLIED DNA SCIENCES INC
YACOV 
 
SHAMASH 
DIRECTOR
APPLIED DNA SCIENCES INC   |  AMERICAN MEDICAL ALERT CORP   |  GOLD COAST BANCORP, INC.
YACOV 
A. 
SHAMASH 
DIRECTOR
APPLIED DNA SCIENCES INC   |  BNB PLUS CORP.
CLAY 
 
SHORROCK 
EXECUTIVE OFFICER
APPLIED DNA SCIENCES INC
CLAY 
D. 
SHORROCK 
EXECUTIVE OFFICER
BNB PLUS CORP.
SANFORD 
R. 
SIMON 
DIRECTOR
APPLIED DNA SCIENCES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-03
D
Link
OTHER 
SERVICES-TESTING LABORATORIES [8734] 
$1,000,001 - $5,000,000 
Equity 
2026-05-28 
2025-10-15
D
Link
BIOTECHNOLOGY 
SERVICES-TESTING LABORATORIES [8734] 
DECLINE TO DISCLOSE 
Equity 
2025-09-29 
2024-11-06
D
Link
BIOTECHNOLOGY 
SERVICES-TESTING LABORATORIES [8734] 
DECLINE TO DISCLOSE 
Equity 
2024-10-30 
2024-02-12
D
Link
BIOTECHNOLOGY 
SERVICES-TESTING LABORATORIES [8734] 
$5,000,001 - $25,000,000 
Equity 
2024-02-02 
2020-10-20
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
$1,000,001 - $5,000,000 
Equity 
2020-10-07 
2019-08-26
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
$1,000,001 - $5,000,000 
Equity 
2019-08-22 
2019-07-19
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
$1,000,001 - $5,000,000 
Debt 
2019-07-16 
2018-09-04
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
$1,000,001 - $5,000,000 
Debt 
2018-08-31 
2017-07-05
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
DECLINE TO DISCLOSE 
Equity 
2017-06-28 
2016-11-14
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
DECLINE TO DISCLOSE 
Equity 
2016-11-07 
2015-12-07
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
DECLINE TO DISCLOSE 
 
2015-11-23 
2014-09-26
D
Link
BIOTECHNOLOGY 
SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] 
$1,000,001 - $5,000,000 
Debt 
2014-09-11 
2014-06-17
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
$1,000,001 - $5,000,000 
Equity 
2014-06-03 
2013-08-02
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
$1,000,001 - $5,000,000 
Equity 
2013-07-19 
2012-12-13
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
$1,000,001 - $5,000,000 
Equity 
2012-11-28 
2012-07-09
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
$1 - $1,000,000 
Equity 
2012-06-21 
2011-07-19
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2011-07-15 
2010-11-26
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-11-17 
2010-07-20
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-07-15 
2009-06-16
D
Link
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-02-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LUCID CAPITAL MARKETS, LLC
000140345
NONE
NONE
CRAIG-HALLUM CAPITAL GROUP LLC
000121395
NONE
NONE
MAXIM GROUP LLC
120708
NONE
NONE
MAXIM GROUP
120708
NONE
NONE
IMPERIAL CAPITAL, LLC
43744
NONE
NONE
MAXIM GROUP LLC
120708
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NO SALES COMPENSATION
NONE
HALCYON CABOT PARTNERS LTD.
32664
MORE THAN FIVE
NONE
INTERMERCHANT SECURITIES LLC
142734
INTERMERCHANT SECURITIES LLC
142734
BASIS FINANCIAL, LLC
43694
MORE THAN FIVE
NONE
ARJENT SERVICES LLC
131431
MORE THAN FIVE
NONE